BioSpace News Archive

Sinclair Pharma Limited, a global aesthetics company headquartered in London and wholly owned by the Chinese company Huadong Medicine Limited, today announces that Silhouette InstaLift ® --has received clearance from Health Canada.

Research focuses on pollutant exposures and impact on human health

Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM), a commercial-stage biopharmaceutical company with eight oncology drug candidates in development around the world and a deep commercial presence in China, today announces its audited financial results for the year ended December 31, 2019 and provides updates on key clinical and commercial developments

DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks

NanoSurface Biomedical received $1.9 million in new funding in 2019 from the National Institutes of Health (NIH) to support accelerated development of NanoSurface’s innovative human induced pluripotent stem cell (iPSC)-based platforms for drug discovery and safety screening.

- Data Presented at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Meeting - - Health State Utility Index Data Estimate the Significant Health Burden of FXS, and Suggest the Potential Benefit of Treatment with Zygel™

The occurrence of Lyme disease, a tick-borne illness, has continued to increase across the U.S. since the year 2000. If left untreated, Lyme disease can lead to life-lasting infection in the joints, nervous system and even the heart.

Global growth equity investor Summit Partners today announced a majority investment in Viroclinics Biosciences B.V. , a leading specialized contract research organization (CRO) serving the global biopharmaceutical industry. The funding will be used to fuel continued expansion of Viroclinics’ services, capacity and international presence.

After the successful launch of MicroPen Elite, a medical-grade micro-needling device, Eclipse, a US-based medical device manufacturer, is excited to introduce Canada and the world to the next generation MicroPen EVO™!

Microbot Medical Inc., announced the appointment of Eyal Morag, M.D., a leading radiologist, to Chief Medical Officer, commencing June 2020.